Abstract
From "one-size-fits-all medicine" to stratified and precision medicine, to network oncology: the paradigm shift in therapeutic approaches in oncology is requiring new care and governance models. Molecular tumor board, network analysis, real-world evidence: only through new tools that do not reduce the complexity of the challenges will it be possible to introduce innovation into the healthcare system.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
